Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Factors in Stage IIB Non-Small Cell Lung Cancer according to the 8th Edition of TNM Staging System

  • Shin, Jin Won (Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Cho, Deog Gon (Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Choi, Si Young (Department of Thoracic and Cardiovascular Surgery, St. Paul's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Park, Jae Kil (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Kyo Young (Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Youngkyu (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2018.11.27
  • Accepted : 2018.12.31
  • Published : 2019.06.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The purposes of this study were to evaluate the appropriateness of the stage migration of stage IIA non-small cell lung cancer (NSCLC) in the seventh edition of the tumor, node, and metastasis classification for lung cancer to stage IIB lung cancer in the eighth edition, and to identify prognostic factors in patients with eighth-edition stage IIB disease. Methods: Patients with eighth-edition stage IIB disease were subclassified into those with seventh-edition stage IIA disease and those with seventh-edition stage IIB disease, and their recurrence-free survival and disease-specific survival rates were compared. Risk factors for recurrence after curative resection were identified in all included patients. Results: Of 122 patients with eighth-edition stage IIB NSCLC, 101 (82.8%) had seventh-edition stage IIA disease and 21 (17.2%) had seventh-edition stage IIB disease. Nonsignificant differences were observed in the 5-year recurrence-free survival rate and the 5-year disease-specific survival rate between the patients with seventh-edition stage IIA disease and those with seventh-edition stage IIB disease. Visceral pleural invasion was a significant risk factor for recurrence in patients with eighth-edition stage IIB NSCLC. Conclusion: The stage migration from seventh-edition stage IIA NSCLC to eighth-edition stage IIB NSCLC was appropriate in terms of oncological outcomes. Visceral pleural invasion was the only prognostic factor in patients with eighth-edition stage IIB NSCLC.

Keywords

References

  1. Didkowska J, Wojciechowska U, Manczuk M, Lobaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med 2016;4:150. https://doi.org/10.21037/atm.2016.03.11
  2. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51. https://doi.org/10.1016/j.jtho.2015.09.009
  3. Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2015;10:990-1003. https://doi.org/10.1097/JTO.0000000000000559
  4. Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 2015;10:1675-84. https://doi.org/10.1097/JTO.0000000000000678
  5. Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:138-55. https://doi.org/10.3322/caac.21390
  6. Travis WD, Asamura H, Bankier AA, et al. The IASLC Lung Cancer Staging Project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2016;11:1204-23. https://doi.org/10.1016/j.jtho.2016.03.025
  7. De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;45:787-98. https://doi.org/10.1093/ejcts/ezu028
  8. Moon Y, Lee KY, Sung SW, Park JK. Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations. J Thorac Dis 2016;8:169-77. https://doi.org/10.3978/j.issn.2072-1439.2016.01.15
  9. Rami-Porta R, Eberhardt WE. Clinical implications of the innovations in the primary tumour and metastasis of the 8(th) edition of the TNM classification for lung cancer. J Thorac Dis 2018;10(Suppl 22):S2682-5. https://doi.org/10.21037/jtd.2018.03.100
  10. Moon Y, Sung SW, Lee KY, Kim YK, Park JK. The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma. World J Surg Oncol 2016;14:37. https://doi.org/10.1186/s12957-016-0791-y
  11. Huang H, Wang T, Hu B, Pan C. Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer. Ann Thorac Surg 2015;99:1130-9. https://doi.org/10.1016/j.athoracsur.2014.11.052
  12. Sakakura N, Mizuno T, Kuroda H, et al. The eighth TNM classification system for lung cancer: a consideration based on the degree of pleural invasion and involved neighboring structures. Lung Cancer 2018;118:134-8. https://doi.org/10.1016/j.lungcan.2018.02.009
  13. Liu QX, Deng XF, Zhou D, Li JM, Min JX, Dai JG. Visceral pleural invasion impacts the prognosis of non-small cell lung cancer: a meta-analysis. Eur J Surg Oncol 2016;42:1707-13. https://doi.org/10.1016/j.ejso.2016.03.012
  14. David E, Thall PF, Kalhor N, et al. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg 2013;95:1872-7. https://doi.org/10.1016/j.athoracsur.2013.03.085
  15. Brotons ML, Bolca C, Frechette E, Deslauriers J. Anatomy and physiology of the thoracic lymphatic system. Thorac Surg Clin 2012;22:139-53. https://doi.org/10.1016/j.thorsurg.2011.12.002
  16. Jiwangga D, Cho S, Kim K, Jheon S. Recurrence pattern of pathologic stage I lung adenocarcinoma with visceral pleural invasion. Ann Thorac Surg 2017;103:1126-31. https://doi.org/10.1016/j.athoracsur.2016.09.052
  17. Tremblay L, Deslauriers J. What is the most practical, optimal, and cost effective method for performing follow-up after lung cancer surgery, and by whom should it be done? Thorac Surg Clin 2013;23:429-36. https://doi.org/10.1016/j.thorsurg.2013.05.010
  18. Kiankhooy A, Taylor MD, LaPar DJ, et al. Predictors of early recurrence for node-negative t1 to t2b non-small cell lung cancer. Ann Thorac Surg 2014;98:1175-83. https://doi.org/10.1016/j.athoracsur.2014.05.061

Cited by

  1. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion vol.146, pp.9, 2019, https://doi.org/10.1007/s00432-020-03276-w